Developing inhaled protein therapeutics for lung diseases

Biologic therapeutics such as protein/polypeptide drugs are conventionally administered systemically via intravenous injection for the treatment of diseases including lung diseases, although this approach leads to low target site accumulation and the potential risk for systemic side effects. In comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, Abigail A., Ee, Pui Lai Rachel, Ge, Ruowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595758/
https://www.ncbi.nlm.nih.gov/pubmed/34765995
http://dx.doi.org/10.1186/s43556-020-00014-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595758/
https://www.ncbi.nlm.nih.gov/pubmed/34765995
http://dx.doi.org/10.1186/s43556-020-00014-z

Ejemplares similares